Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 3.1B | 3.2B | 3.2B |
Cost of revenue | 1.9B | 2.0B | 2.0B | 2.0B |
Gross profit | 1.1B | 1.1B | 1.2B | 1.2B |
Operating expense | ||||
Research & development | 137M | 138M | 134M | 134M |
Selling general and admin | 369M | 363M | 387M | 415M |
Other operating expenses | — | — | — | — |
Operating income | 494M | 478M | 524M | 475M |
Non operating interest income | ||||
Income | 21M | 18M | 14M | 21M |
Expense | 83M | 84M | 87M | 99M |
Other income expense | -861M | -369M | 135M | -101M |
Pretax income | -429M | 43M | 586M | 296M |
Tax provision | 119M | 104M | 106M | 120M |
Net income | -582M | -106M | 462M | 185M |
Basic EPS | — | -0.3 | 1.1 | 0.4 |
Diluted EPS | — | -0.3 | 1.1 | 0.4 |
Basic average shares | — | 418.3M | 417.9M | 417.8M |
Diluted average shares | — | 418.3M | 419.5M | 419.3M |
EBITDA | 812M | 815M | 868M | 823M |
Net income from continuing op. | -548M | -61M | 480M | 176M |
Minority interests | -7M | -12M | -8M | -7M |
Preferred stock dividends | — | — | — | — |